Epistaxis Market Forecast, Trend Analysis & Competition Tracking – Global Market insights 2017 to 2026

Published on : Dec-2017 | List of Tables : 131 | List of Figures : 81 | No. of Pages : 170 | Report Code : FACT344MR | Format :

Conditions that predispose a person to nosebleeds include dry and less humid weather conditions and increasing prevalence of hypertension. According to World Health Organization (WHO), over 12% of the deaths caused globally are due to hypertension. Incidence of nosebleeds continue to increase with the increasing cases of hypertension. Moreover, prevalence of hypertension in pregnant women leads to increasing blood flow towards the mucous membrane. Such factors continue to rev up demand for the epistaxis products in the global market.

epistaxis market

According to Fact.MR, the global epistaxis market is expected to represent a value of nearly US$ 13 Mn by the end of 2026.

Market Taxonomy

Region

Product

Distribution Channel

Indication

North America

Vasoconstrictors

Hospitals

Posterior Epistaxis

Latin America

Anesthetics

Specialty Clinics

Anterior Epistaxis

Europe

Antibiotic Ointments

Retail Pharmacies

 

Japan

Cauterizing Agents

Other Distribution Channels

 

APEJ

     

MEA

     

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Extreme Weather Conditions to Impact Global Market Growth

Epistaxis continues to remain a common health problem observed among the adults and children. Impact of extreme weather conditions can lead to crusting of the mucous secretion processes, which can result into cracks in the nose lining. Extreme dryness and heat in the air can result in dry nasal membrane and eliminates the amount of moisture required to be maintained in the nose. Frequent changes in the environmental conditions such as less humid weather and extremely cold winters lead to increasing instances of dry nasal membrane. Dry nasal membrane leads to increasing occurrences of nosebleeds during the hot, cold and dry weather. Increasing incidences of dry nasal membrane and abnormal nosebleeds is expected to boost demand for epistaxis products during the forecast period. 

Innovative Surgeries to Underscore Lucrative Growth Opportunities

Manufacturers are focusing on developing epistaxis products that offer improved performance and result. Incorporation of innovation in the epistaxis products has led to more effective and advanced treatment procedures for epistaxis. Innovative treatment procedures include various surgical and non-surgical interventional procedure. Innovative treatment for nasal packing, embolization and warm water irrigation are a few non-interventional surgeries.

Endoscopic litigation of sphenopaletine artery, maxillary, artery litigation and nasal cauterization are the innovative treatments that include surgical intervention. Adoption of innovative surgeries are significantly changing the trends in the global epistaxis market. Moreover, manufacturers are increasingly focusing on developing epistaxis products for the treatment of patients with special medical conditions such as asthma, pregnancy, diabetes and cancer. These factors are expected to contribute towards growth of the global epistaxis market during the forecast period.

Anterior Indication to Represent a Leading Segment

With the growing incidences of nose cauterization among the children and adults has led to surge in demand for cauterization agents in the global market. On the basis of product type, the cauterization agents segment is expected to represent the highest revenue growth, accounting for a value of over US$ 30 Mn by the end of 2026. On the other hand, the antibiotic ointment product type segment is expected to register a significant CAGR during the forecast period.

Based on distribution channel, the retail pharmacies segment is expected to generate significant revenues, accounting for a value of nearly US$ 20 Mn by the end of 2017. However, the specialty clinics distribution channel segment is expected to register a robust CAGR through 2026.

By indication, the anterior segment is expected to represent a robust revenue growth, recording a value of nearly US$ 80 Mn by the end of 2026. In contrary, the posterior indication segment is expected to register a healthy CAGR throughout the forecast period.

Competition Tracking

Leading market players operating on the global epistaxis market include Bristol-Myers Squibb Company, Ciron Drugs & Pharmaceuticals Pvt. Ltd., Pfizer Inc., Medline Industries, Inc., Smith & Nephew, GlaxoSmithKline PLC and Ferring B.V.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Growing prevalence of hypertension is expected to impact the global epistaxis market. Instances of dry mucous membrane attributed to extreme weather conditions will continue to rev up demand for epistaxis products globally. This Fact.MR report analyzes the expansion of global epistaxis market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.

Scope

The scope of Fact.MR’s report is to analyze the global epistaxis market for the forecast period 2017-2026 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global epistaxis market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to epistaxis.

Summary

The report commences with a brief information of the global epistaxis market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global epistaxis market.

Overview

The next section offers an overview of the global epistaxis market. This comprises an introduction to the market, along with a standard definition of the product – epistaxis. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

In order to offer readers with up-to-date information about the latest advancements in the global epistaxis market, the report provides updates about market opportunities, which can benefit leading manufacturers of epistaxis. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for tissue expander manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.

The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global epistaxis market. Product type, distribution channel, indication, and region are key segments that define the growth of the global market for epistaxis. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.

The report’s last section comprises of the global epistaxis market competitive landscape, to provide readers with the dashboard view of company analysis and market players. This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global epistaxis market.

Research Methodology

Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,

  • Primary research
  • Secondary research
  • Trade research
  • Focused interviews
  • Social media analysis

Chapter 1 Global Outlook

Chapter 2 Global Epistaxis Market - Executive Summary

Chapter 3 Global Epistaxis Market Overview
3.1 Introduction
      3.1.1 Global Epistaxis Market Taxonomy
      3.1.2 Global Epistaxis Market Definition
3.2 Global Epistaxis Market Size (US$ Mn) and Forecast, 2012-2026
      3.2.1 Global Epistaxis Market Y-o-Y Growth
3.3 Global Epistaxis Market Dynamics
3.4 Supply Chain
3.5 Cost Structure
3.6 Epistaxis Epidemiology
3.7 Key Regulations
3.8 Patent Analysis
3.9 PESTL Analysis
3.10 Product Lifecycle
3.11 Pricing Analysis
3.12 Service Provider List
3.13 Key Participants Market Presence (Intensity Map) By Region

Chapter 4 Global Epistaxis Market Analysis and Forecast 2012-2026
4.1 Global Epistaxis Market Size and Forecast by Product, 2012-2026
      4.1.1 Vasoconstrictors Market Size and Forecast, 2012-2026
              4.1.1.1 Revenue (US$ Mn) Comparison, By Region
              4.1.1.2 Market Share Comparison, By Region
              4.1.1.3 Y-o-Y growth Comparison, By Region
      4.1.2 Anesthetics Market Size and Forecast, 2012-2026
              4.1.2.1 Revenue (US$ Mn) Comparison, By Region
              4.1.2.2 Market Share Comparison, By Region
              4.1.2.3 Y-o-Y growth Comparison, By Region
      4.1.3 Antibiotic Ointments Market Size and Forecast, 2012-2026
              4.1.3.1 Revenue (US$ Mn) Comparison, By Region
              4.1.3.2 Market Share Comparison, By Region
              4.1.3.3 Y-o-Y growth Comparison, By Region
      4.1.4 Cauterizing Agents Market Size and Forecast, 2012-2026
              4.1.4.1 Revenue (US$ Mn) Comparison, By Region
              4.1.4.2 Market Share Comparison, By Region
              4.1.4.3 Y-o-Y growth Comparison, By Region
4.2 Global Epistaxis Market Size and Forecast by Distribution Channel, 2012-2026
      4.2.1 Hospitals Market Size and Forecast, 2012-2026
              4.2.1.1 Revenue (US$ Mn) Comparison, By Region
              4.2.1.2 Market Share Comparison, By Region
              4.2.1.3 Y-o-Y growth Comparison, By Region
      4.2.2 Specialty Clinics Market Size and Forecast, 2012-2026
              4.2.2.1 Revenue (US$ Mn) Comparison, By Region
              4.2.2.2 Market Share Comparison, By Region
              4.2.2.3 Y-o-Y growth Comparison, By Region
      4.2.3 Retail Pharmacies Market Size and Forecast, 2012-2026
              4.2.3.1 Revenue (US$ Mn) Comparison, By Region
              4.2.3.2 Market Share Comparison, By Region
              4.2.3.3 Y-o-Y growth Comparison, By Region
      4.2.4 Other Distribution Channels Market Size and Forecast, 2012-2026
              4.2.4.1 Revenue (US$ Mn) Comparison, By Region
              4.2.4.2 Market Share Comparison, By Region
              4.2.4.3 Y-o-Y growth Comparison, By Region
4.3 Global Epistaxis Market Size and Forecast by Indication, 2012-2026
      4.3.1 Posterior Epistaxis Market Size and Forecast, 2012-2026
              4.3.1.1 Revenue (US$ Mn) Comparison, By Region
              4.3.1.2 Market Share Comparison, By Region
              4.3.1.3 Y-o-Y growth Comparison, By Region
      4.3.2 Anterior Epistaxis Market Size and Forecast, 2012-2026
              4.3.2.1 Revenue (US$ Mn) Comparison, By Region
              4.3.2.2 Market Share Comparison, By Region
              4.3.2.3 Y-o-Y growth Comparison, By Region

Chapter 5 North America Epistaxis Market Size and Forecast, 2012-2026
5.1 Region Outlook
      5.1.1 Political Outlook
      5.1.2 Economic Outlook
      5.1.3 Business Environment Outlook
      5.1.4 North America Healthcare Sector Outlook
      5.1.5 Epistaxis Market: North America Region Analysis
5.2 Revenue (US$ Mn) Comparison, By Country
5.3 Revenue (US$ Mn) Comparison, By Product
5.4 Revenue (US$ Mn) Comparison, By Distribution Channel
5.5 Revenue (US$ Mn) Comparison, By Indication

Chapter 6 Latin America Epistaxis Market Size and Forecast, 2012-2026
6.1 Region Outlook
      6.1.1 Political Outlook
      6.1.2 Economic Outlook
      6.1.3 Business Environment Outlook
      6.1.4 Latin America Healthcare Sector Outlook
      6.1.5 Epistaxis Market: Latin America Region Analysis
6.2 Revenue (US$ Mn) Comparison, By Country
6.3 Revenue (US$ Mn) Comparison, By Product
6.4 Revenue (US$ Mn) Comparison, By Distribution Channel
6.5 Revenue (US$ Mn) Comparison, By Indication

Chapter 7 Europe Epistaxis Market Size and Forecast, 2012-2026
7.1 Region Outlook
      7.1.1 Political Outlook
      7.1.2 Economic Outlook
      7.1.3 Business Environment Outlook
      7.1.4 Europe Healthcare Sector Outlook
      7.1.5 Epistaxis Treatment Market: Europe Region Analysis
7.2 Revenue (US$ Mn) Comparison, By Country
7.3 Revenue (US$ Mn) Comparison, By Product
7.4 Revenue (US$ Mn) Comparison, By Distribution Channel
7.5 Revenue (US$ Mn) Comparison, By Indication

Chapter 8 Japan Epistaxis Market Size and Forecast, 2012-2026
8.1 Region Outlook
      8.1.1 Political Outlook
      8.1.2 Economic Outlook
      8.1.3 Business Environment Outlook
      8.1.4 Japan Healthcare Sector Outlook:
      8.1.5 Epistaxis Market: Japan Region Analysis
8.2 Revenue (US$ Mn) Comparison, By Country
8.3 Revenue (US$ Mn) Comparison, By Product
8.4 Revenue (US$ Mn) Comparison, By Distribution Channel
8.5 Revenue (US$ Mn) Comparison, By Indication

Chapter 9 APEJ Epistaxis Market Size and Forecast, 2012-2026
9.1 Region Outlook
      9.1.1 Political Outlook
      9.1.2 Economic Outlook
      9.1.3 Business Environment Outlook
      9.1.4 Asia Pacific Excluding Japan (APEJ) Healthcare Sector Outlook
      9.1.5 Epistaxis Market: APEJ Region Analysis
9.2 Revenue (US$ Mn) Comparison, By Country
9.3 Revenue (US$ Mn) Comparison, By Product
9.4 Revenue (US$ Mn) Comparison, By Distribution Channel
9.5 Revenue (US$ Mn) Comparison, By Indication

Chapter 10 MEA Epistaxis Market Size and Forecast, 2012-2026
10.1 Region Outlook
      10.1.1 Political Outlook
      10.1.2 Economic Outlook
      10.1.3 Business Environment Outlook
      10.1.4 Middle East & Africa (MEA) Healthcare Sector Outlook
      10.1.5 Epistaxis Market: MEA Region Analysis
10.2 Revenue (US$ Mn) Comparison, By Country
10.3 Revenue (US$ Mn) Comparison, By Product
10.4 Revenue (US$ Mn) Comparison, By Distribution Channel
10.5 Revenue (US$ Mn) Comparison, By Indication

Chapter 11 Global Epistaxis Treatment Market – Company Share Analysis, Competitive Landscape and Company Profiles
11.1 Global Epistaxis Treatment Market – Company Share Analysis
11.2 Global Epistaxis Treatment Market – Competitive Landscape
11.3 Global Epistaxis Treatment Market – Company Profiles
      11.3.1 Bristol-Myers Squibb Co.
              11.3.1.1 Company Overview
              11.3.1.2 Product Overview
              11.3.1.3 Key Financials
              11.3.1.4 Key Developments
              11.3.1.5 SWOT Analysis
      11.3.2 Ciron Drugs & Pharmaceuticals Pvt. Ltd.
              11.3.2.1 Company Overview
              11.3.2.2 Product Overview
      11.3.3 Pfizer Inc.
              11.3.3.1 Company Overview
              11.3.3.2 Product Overview
              11.3.3.3 Key Financials
              11.3.3.4 Key Developments
              11.3.3.5 SWOT Analysis
      11.3.4 Medline Industries, Inc
              11.3.4.1 Company Overview
              11.3.4.2 Product Overview
              11.3.4.3 SWOT Analysis
      11.3.5 Smith & Nephew Plc.
              11.3.5.1 Company Overview
              11.3.5.2 Product Overview
              11.3.5.3 Key Financials
              11.3.5.4 SWOT Analysis
      11.3.6 GlaxoSmithKline PLC
              11.3.6.1 Company Overview
              11.3.6.2 Product Overview
              11.3.6.3 Key Financials
              11.3.6.4 Key Developments
              11.3.6.5 SWOT Analysis
      11.3.7 Ferring B.V.
              11.3.7.1 Company Overview
              11.3.7.2 Product Overview
11.4 Key Takeaways

Chapter 12 Fact.MR Research Methodology

Chapter 13 Disclaimer

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Epistaxis Market Forecast, Trend Analysis & Competition Tracking – Global Market insights 2017 to 2026